The Biden administration has revealed the first 10 medications that will be subject to price negotiations between manufacturers and Medicare under the Inflation Reduction Act, according to an Aug. 29 report from CNBC.
1st 10 drugs subject to payer negotiations under controversial Inflation Reduction Act
